15-65384196-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020962.3(IGDCC4):āc.3566T>Cā(p.Leu1189Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000683 in 1,610,530 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020962.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IGDCC4 | NM_020962.3 | c.3566T>C | p.Leu1189Pro | missense_variant | 20/20 | ENST00000352385.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IGDCC4 | ENST00000352385.3 | c.3566T>C | p.Leu1189Pro | missense_variant | 20/20 | 1 | NM_020962.3 | P1 | |
IGDCC4 | ENST00000559327.1 | n.2835T>C | non_coding_transcript_exon_variant | 14/14 | 1 | ||||
IGDCC4 | ENST00000558048.5 | n.698T>C | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152086Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248626Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134602
GnomAD4 exome AF: 0.00000686 AC: 10AN: 1458444Hom.: 0 Cov.: 30 AF XY: 0.00000690 AC XY: 5AN XY: 725080
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152086Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2022 | The c.3566T>C (p.L1189P) alteration is located in exon 20 (coding exon 20) of the IGDCC4 gene. This alteration results from a T to C substitution at nucleotide position 3566, causing the leucine (L) at amino acid position 1189 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at